Clinical Trial Update: Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated the metabolic effects of the probiotic Lactobacillus reuteri DSM 17938 in individuals with Type 2 diabetes mellitus. The re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Type 2 Diabetes | NA | Status: COMPLETED